Healthcare & Medical Devices Global On demand · 24-48h

Global Disposable Biopsy Valve Market Strategic Research Report

Global Disposable Biopsy Valve Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Disposable Biopsy Valve Market
$1.37B2025
7.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Rotatable, Not Rotatable

By Application: Hospitals, Clinics, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Cantel Medical Corporation, STERIS, CONMED Corporation, Olympus America, Diversatek Healthcare, Andorate, Endoss Medical, Duomed Group, Smart Data Medical, FORESIGHT TECHNOLOGY

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 97 pages
Market size 2025
$1.37B
Billion USD
Forecast CAGR
7.3%
2025-2032
Forecast 2032
$2.2B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Disposable Biopsy Valve market size is predicted to grow from US$ 1,367 million in 2025 to US$ 2,231 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

A disposable biopsy valve is a medical device used in endoscopic procedures to obtain tissue samples. It is mainly used in gastrointestinal endoscopy, bronchoscopy, and other endoscopic procedures. It usually consists of a valve and a sample collection container. The valve is often made of elastic materials and is designed with a unique structure, such as an arc - shaped one - way valve with a small hole in the middle for the passage of endoscopic surgical instruments like biopsy forceps.

During endoscopic examinations or surgeries, the biopsy valve is inserted into the working channel of the endoscope and positioned at the site where samples need to be collected. Doctors can open the biopsy valve through the endoscope's handle or remote control, connecting the inside of the sample collection container to the endoscope's working channel. Then, the sample is sucked into the container through the biopsy valve by applying appropriate negative pressure.

The demand for disposable biopsy valves is increasing due to the rising preference for disposable biopsy devices. As an important part of biopsy devices, Disposable Biopsy Valves are expected to grow in line with the overall market trend.

The rising incidence of cancer and other chronic diseases has led to an increased demand for biopsies for accurate diagnosis and treatment planning. Disposable biopsy valves are essential in endoscopic procedures for obtaining tissue samples, and thus the growing demand for biopsies directly drives the growth of the disposable biopsy valve market.

The development of minimally - invasive surgical techniques has led to a wider application of endoscopic procedures. Disposable biopsy valves, which are widely used in endoscopic tissue sampling, offer advantages such as convenience, safety, and reliability, and are therefore favored by medical professionals.

Strict regulations regarding medical device hygiene and safety have been introduced worldwide. Disposable biopsy valves, being single - use devices, help reduce the risk of cross - infection, meet regulatory requirements, and are thus increasingly used in medical institutions.

North America is expected to have the highest revenue share. This is attributed to the high prevalence of cancer, the increasing demand for technologically advanced devices, and the growing preference for disposable medical devices in this region. In addition, the well - developed medical insurance system and high - quality medical resources also provide a good market environment for the sales of disposable biopsy valves.

Asia-Pacific is a region with significant growth potential. The growing economy, the improvement of healthcare infrastructure, and the increasing awareness of disease prevention and treatment have led to a continuous increase in the demand for medical devices in this region. Moreover, the large population base and the high incidence of certain diseases also provide a broad market space for disposable biopsy valves.

This report presents a comprehensive overview of the global Disposable Biopsy Valve market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Rotatable
  • Not Rotatable

Segment by Application

  • Hospitals
  • Clinics
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Disposable Biopsy Valve market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Clinics, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Disposable Biopsy Valve Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.37B
2025
Forecast
$2.2B
2032
CAGR
7.3%
2025–2032
Régions
5
global
Key companies
Cantel Medical CorporationSTERISCONMED CorporationOlympus AmericaDiversatek HealthcareAndorateEndoss MedicalDuomed Group
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
RotatableNot Rotatable
By Application
HospitalsClinicsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Rotatable
  • 3.1.3 Not Rotatable
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Clinics
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Cantel Medical Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 STERIS
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 CONMED Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Olympus America
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Diversatek Healthcare
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Andorate
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Endoss Medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Duomed Group
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Smart Data Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 FORESIGHT TECHNOLOGY
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Disposable Biopsy Valve market size?
The global Disposable Biopsy Valve market is estimated at US$ 1.37 billion in 2025 (base year) and is projected to reach US$ 2.23 billion by 2032.
What growth rate is expected for the Disposable Biopsy Valve market through 2032?
The market is expected to grow at a CAGR of 7.3% from 2026 to 2032, expanding from US$ 1.37 billion in 2025 to US$ 2.23 billion in 2032, roughly 1.6 times its base-year value.
How is Disposable Biopsy Valve defined?
A disposable biopsy valve is a medical device used in endoscopic procedures to obtain tissue samples. It is mainly used in gastrointestinal endoscopy, bronchoscopy, and other endoscopic procedures. It usually consists of a valve and a sample collection container.
How is the Disposable Biopsy Valve market segmented by type?
By type, the market is segmented into Rotatable and Not Rotatable.
What are the key applications of Disposable Biopsy Valve?
Key applications covered include Hospitals, Clinics and Others.
Which companies are profiled in the Disposable Biopsy Valve market report?
Key players profiled include Cantel Medical Corporation, STERIS, CONMED Corporation, Olympus America, Diversatek Healthcare, Andorate, Endoss Medical and Duomed Group, among 10 companies covered in total.
What geographies does the Disposable Biopsy Valve market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Disposable Biopsy Valve?
Disposable biopsy valves are essential in endoscopic procedures for obtaining tissue samples, and thus the growing demand for biopsies directly drives the growth of the disposable biopsy valve market.
Who should buy the Disposable Biopsy Valve market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Clinics and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Disposable Biopsy Valve market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.